Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Human endocarditis due to nutritionally variant streptococci: Streptococcus adjacens and Streptococcus defectivus
Université Paris VI, Hôpital Hôtel Dieu, Laboratoire de Microbiologie Paris France
Correspondence: A. Bouvet. 1. place du Parvis Notre-Dame. F-75181 Paris 04. France
Streptococcus adjacens and S. defectivus are two recently individualized species of viridans streptococci. Both species were previously designated as nutritionally variant streptococci and characterized by their growth as small satellite colonies supported by helper bacteria, or requiring complex media enriched with cysteine or with pyridoxal. Structural abnormalities were observed under these conditions and balanced growth can be obtained only with a semi-chemically defined medium, in which the cells are morphologically normal and exhibit a parietal chromophore. The two species are primarily isolated from the oral cavity, or from intestinal and genito-urinary tracts. They are likely to be responsible for most blood-culture-negative endocarditis and account for more than 4% of streptococcal strains isolated from blood cultures during this disease. Cases of endocarditis caused by these bacteria exhibit much higher rates of failure, relapse and mortality than those due to other viridans streptococci. The slow growth rate of the bacteria and the production of large amounts of exopolysaccharide in vivo may account for the difficulties encountered in treatment and suggest that a longer course of antimicrobial therapy may be required for successful cures. Results obtained from experimental models of endocarditis confirmed the efficacy of vancomycin as an alternative therapy in patients when a combination of penicillin and aminoglycoside is ineffective or contraindicated.
Key Words: Streptococcus adjacens Streptococcus defectivus endocarditis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. M. Grandi, D. Imperiale, R. Santillo, E. Barlocco, A. Bertolini, L. Guasti, and A. Venco Aldosterone Antagonist Improves Diastolic Function in Essential Hypertension Hypertension, November 1, 2002; 40(5): 647 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dieez and C. Laviades Monitoring fibrillar collagen turnover in hypertensive heart disease Cardiovasc Res, August 1, 1997; 35(2): 202 - 205. [Full Text] [PDF] |
||||

